Contact this trialFirst, we need to learn more about you.
Melanocortin 4 Receptor (MC4R) Agonist
Setmelanotide for Bardet-Biedl Syndrome
Recruiting2 awardsPhase 3
New York, New York
This trial is testing setmelanotide, a drug that may help with weight loss, in children aged 2-6 with obesity due to certain genetic conditions. The trial will last for one year to evaluate the safety and effectiveness of the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.